$CTLT News
Last published 4mo ago
- 4mo agoCTLTApproval of Valproic Acid, Anda #073229 (Manufacturing (CMC))FDA Approved DrugsApproval Date: 06/25/2026; Drug Name: Valproic Acid, Anda #073229; Active Ingredients: VALPROIC ACID; Company: Catalent; Submission Status: Approval; Submission Classification: Manufacturing (CMC); Application Number: 073229
- 1y agoCTLTCatalent Announces New Board AppointmentsBusiness WireAdds three new directors with deep expertise across biopharma and life sciences Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has
- 1y agoLIICTLTBILLSPGILennox International Set to Join S&P 500 and BILL Holdings to Join S&P MidCap 400PR NewswireS&P MidCap 400 constituent Lennox International Inc. (NYSE: LII) will replace Catalent Inc. (NYSE: CTLT) in the S&P 500, and BILL Holdings Inc....
- 1y agoCTLTNovo Holdings Completes Acquisition of CatalentBusiness WireCatalent to Strengthen its Leading Position as a Global Service Provider for the Pharma and Biotech Industry under Private Ownership Catalent, Inc. ("Catalent"), a leader in enabling the development and supply of
- 1y agoCTLTCatalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending TransactionBusiness WireTransaction Expected to Close in the Coming Days Catalent, Inc. (("Catalent, NYSE:CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S ("Novo
- 1y agoCTLTHYPRNVSTQDELQuidelOrtho Announces Appointment of Two Independent Directors to its BoardBusiness WireVeteran Healthcare CEOs John R. Chiminski and R. Scott Huennekens Bring Deep Industry Experience, Operational Expertise and Financial Acumen to the QuidelOrtho Board QuidelOrtho Corporation (NASDAQ:QDEL) (the
- 1y agoCTLTCatalent and Novo Holdings Receive European Commission Unconditional Approval for Pending TransactionBusiness WireTransaction Expected to Close Towards the End of Calendar Year 2024 Catalent, Inc. (("Catalent, NYSE:CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo
- 2y agoCTLTCatalent, Inc. Reports First Quarter Fiscal 2025 ResultsBusiness WireQ1'25 net revenue of $1.02 billion increased 4% as reported and in constant currency(1), compared to Q1'24. Q1'25 net revenue, excluding COVID revenue of ~$30 million in Q1'25 and ~$100 million in
- 2y agoCTLTCatalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo HoldingsBusiness WireCommitted to Continuing to Serve Customers and Patients as a Leading Global, Independent, Full-Service CDMO Post-Close Alessandro Maselli to Remain President and CEO of Catalent Post-Close Catalent, Inc. (NYSE:CTLT),
- 2y agoCTLTCatalent Signs Agreement to Sell Somerset, NJ Oral Solids FacilityBusiness WireCatalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, announced today that it has entered into a definitive agreement to sell its oral solids
- 2y agoCTLTCatalent, Inc. Reports Fourth Quarter and Fiscal 2024 ResultsBusiness WireQ4'24 net revenue of $1.30 billion increased 23% as reported, or 24% in constant currency, compared to Q4'23. Organic, constant-currency net revenue increased 24%, compared to Q4'23. Q4'24 net
- 2y agoCTLTCatalent Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, GermanyBusiness WireExpansion adds more temperature-controlled storage and dedicated space for FastChain® demand-led supply service Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments
- 2y agoCTLTArdena appoints Jeremie Trochu as Chief Executive OfficerPR NewswireArdena (the "Company") today announces the retirement of Harry Christiaens, PhD and the subsequent appointment of Jeremie Trochu as Chief Executive...
- 2y agoCTLTCatalent Stockholders Approve Transaction with Novo HoldingsBusiness WireCatalent, Inc. (("Catalent, NYSE:CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, today announced that, at its Special Meeting of Stockholders (the "Special Meeting")
- 2y agoCTLTCatalent, Inc. Reports Third Quarter Fiscal 2024 ResultsBusiness WireQ3'24 net revenue of $1.07 billion increased 4% as reported, or 3% in constant currency(1), compared to Q3'23. Q3'24 net revenue, excluding COVID-related revenue of ~$120 million in Q3'23 and ~$60
- 2y agoCTLTRobbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT)Business WireShareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Catalent, Inc. (NYSE:CTLT) by Novo Holdings, a holding and investment company that is responsible for managing the assets
- 2y agoCTLTRobbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo HoldingsGlobeNewswireSAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Catalent, Inc. (NYSE:CTLT) by Novo Holdings, a holding and investment
- 2y agoCTLTHRTNGMSDPIKuehn Law Encourages NGM, CTLT, SDPI, and HRT Investors to Contact Law FirmGlobeNewswireNEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
- 2y agoCTLTCatalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term CommitmentBusiness WireCommits to reducing Scope 1 and 2 greenhouse gas emissions by 42% from its 2022 baseline by 2030, with commitment to ensuring 70% of supplier emissions have science-based targets by end of fiscal 2028. Implemented
- 2y agoCHRDAVROKAMNCTLTKuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law FirmPR NewswireKuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may...
- 2y agoNVONOVO.B-DKLLYAMGN+4Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change thatCNBCNovo Nordisk and Eli Lilly have given positive supply updates, aiming to reassure investors that they can continue to capitalize on the success of their drugs.
- 2y agoCTLTCatalent, Inc. Reports Second Quarter Fiscal 2024 ResultsBusiness WireQ2'24 net revenue of $1.03 billion decreased 10% as reported, or 11% in constant currency(1), compared to Q2'23. Q2'24 net revenue, excluding COVID-related revenue of ~$260 million in Q2'23 and ~$75
- 2y agoCTLTCTLT Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Catalent, Inc. for Potential Securities Law ViolationsGlobeNewswireMONSEY, N.Y., Feb. 07, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether Catalent, Inc. (NYSE:CTLT) ("Catalent") has violated federal securities laws based on a report by
- 2y agoCTLTEVBGSLAMZFOXKuehn Law Encourages ZFOX, CTLT, SLAM, and EVBG Investors to Contact Law FirmGlobeNewswireNEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
- 2y agoCTLTCTLT Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Catalent to Novo HoldingsGlobeNewswireMONSEY, N.Y., Feb. 05, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the price of $63.50 per share in cash for which Catalent, Inc. (NYSE:CTLT) ("Catalent") has
- 2y agoCTLTNOVO.B-DKLLYNovo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supplyCNBCCatalent is the main supplier of fill-finish work, which involves filling and packaging syringes and injection pens, for Novo Nordisk's Wegovy.
- 2y agoCTLTNovo Holdings to Acquire CatalentBusiness WireCatalent Stockholders to Receive $63.50 Per Share in Cash, Representing a 47.5% Premium to the 60-day Volume-Weighted Average Price as of February 2, 2024 Catalent, Inc. (NYSE:CTLT), a leader in enabling the
- 2y agoCTLTCatalent, Inc. Announces Second Quarter Fiscal Year 2024 Earnings Conference WebcastBusiness WireCatalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it will release financial results for the second quarter of fiscal year
- 2y agoCTLTCatalent Commits to Reducing Greenhouse Gas Emissions by 2030Business WireNew targets approved by Science Based Targets initiative (SBTi) Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced its targets to
- 2y agoCTLTCatalent, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceBusiness WireCatalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that members of its executive leadership team will participate at the 42nd
- 2y agoCTLTCatalent Announces Closing of Incremental Term LoansBusiness WireCatalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, announced today that its wholly owned subsidiary, Catalent Pharma Solutions, Inc., as borrower,
- 2y agoCTLTCatalent Regains Compliance with NYSE Continued Listing StandardsBusiness WireCatalent, Inc. ("Catalent" or the "Company") (NYSE:CTLT) announced today that the Company has received written notification ("Notice") from the New York Stock Exchange ("NYSE") that it has officially regained compliance
- 2y agoCTLTCatalent, Inc. (CTLT) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoCTLTCatalent, Inc. Reports Preliminary First Quarter Fiscal 2024 Results and Reaffirms Full-Year Fiscal 2024 GuidanceBusiness WireQ1'24 net revenue of $982 million decreased 4% as reported, or 6% in constant currency(1), compared to Q1'23. Organic, constant-currency net revenue decreased by 8%, compared to Q1'23. Q1'24 net
- 2y agoCTLTQTRXSHCWSTSotera Health Appoints Karen Flynn to Board of DirectorsGlobeNewswireCLEVELAND, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare
- 3y agoCTLTCatalent, Inc. Announces First Quarter Fiscal Year 2024 Earnings Conference WebcastBusiness WireCatalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it will release preliminary financial results for the first quarter of
- 3y agoCTLTTMOViroCell Expands Business Development Team to Support Next Phase of GrowthBusiness WireTraci Kyes and Makis Sigalas bring extensive industry experience to roles focused on expanding ViroCell's business in the US and Europe Team ViroCell will be attending the Cell & Gene Therapy Meeting on the Mesa,
- 3y agoCTLTApproval of Naproxen Sodium, Anda #202807 (Labeling)FDA Approved DrugsApproval Date: 09/19/2023; Drug Name: Naproxen Sodium, Anda #202807; Active Ingredients: NAPROXEN SODIUM; Company: Catalent; Submission Status: Approval; Submission Classification: Labeling; Application Number: 202807
- 3y agoCTLTCatalent Appoints David McErlane as Biologics Segment LeaderBusiness WireCatalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that David McErlane has been named Group President of Catalent's Biologics
- 3y agoCTLTCatalent Receives NYSE Notice Regarding Late Form 10-K FilingBusiness WireCatalent, Inc. ("Catalent" or the "Company") (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that, on September 14, 2023, it received a notice
- 3y agoCTLTCatalent, Inc. to Present at September Investor ConferencesBusiness WireCatalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that members of its executive leadership team will participate at two upcoming
- 3y agoBBYBIGCOINMARA+20Stocks making the biggest moves midday: Best Buy, Big Lots, Coinbase, Nio and moreCNBCThese are the stocks posting the largest moves in midday trading Tuesday.
- 3y agoCTLTCatalent Announces Governance Enhancements and New Initiatives to Drive ValueBusiness WireAdding Four New Independent Directors Appoints John Greisch as Executive Chair Establishes New Strategic and Operational Review Committee of the Board Enters into Cooperation Agreement with Elliott Investment
- 3y agoCTLTCatalent, Inc. Reports Preliminary Fourth Quarter and Fiscal 2023 ResultsBusiness WireQ4'23 net revenue of $1.07 billion decreased (17)% as reported, or (17)% in constant currency, compared to Q4'22. Organic, constant-currency net revenue decreased (19)%, compared to Q4'22. Fiscal 2023
- 3y agoCTLTCatalent, Inc. Announces Fourth Quarter Fiscal Year 2023 Earnings Conference WebcastBusiness WireCatalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it will release financial results for the fourth quarter of fiscal year
- 3y agoCTLTCatalent Appoints Lisa Evoli Senior Vice President and Chief Human Resources OfficerBusiness WireCatalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that Lisa Evoli has been named Senior Vice President & Chief Human Resources
- 3y agoCTLTCatalent Appoints Matti Masanovich Senior Vice President & Chief Financial OfficerBusiness WireCatalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that Matti Masanovich has been named Senior Vice President & Chief Financial
- 3y agoCTLTCatalent Regains Compliance with NYSE Continued Listing StandardsBusiness WireCatalent, Inc. ("Catalent" or the "Company") (NYSE:CTLT) announced today that the Company has received written notification ("Notice") from the New York Stock Exchange ("NYSE") that it has officially regained compliance
- 3y agoCCLNCLHRCLKDNY+7Stocks making the biggest moves midday: Carnival, Nasdaq, Oracle, KeyCorp and moreCNBCThese are the stocks posting the largest moves midday.
- 3y agoCTLTCatalent, Inc. Reports Third Quarter Fiscal 2023 ResultsBusiness WireQ3'23 net revenue of $1.04 billion decreased 19% as reported, or 17% in constant currency(1), compared to Q3'22. Organic, constant-currency net revenue decreased by 19%, compared to Q3'22. Q3'23 net